Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

12345678910...
CompanyDrug NameStatusIndication Group
GlaxoSmithKline Ziagen/Epivir Submitted for approval in USAAnti-infectives for systemic use
GlaxoSmithKline Ziagen Approved in USAAnti-infectives for systemic use
Biogen Idec ZEVALIN Approved in EUAntineoplastic & immunomodulating agents
Keryx Bio Zerenex accomplished Phase IIGenito urinary system & sex hormones
Santarus Zeregid Approved in USAAlimentary tract & metabolism
Santarus Zeregid Approved in USAAlimentary tract & metabolism
Hana Biosciences Zensana in Phase INervous system
Abbott Laboratories Zemplar Approved in USASystemic hormonal preparations
Abbott Laboratories Zemplar Approved in USASystemic hormonal preparations
Novartis Zelnorm / Zelmac Approved in USAAlimentary tract & metabolism
Novartis Zelnorm / Zelmac in Phase IIIAlimentary tract & metabolism
Novartis Zelnorm / Zelmac in Phase IIAlimentary tract & metabolism
Novartis Zelnorm / Zelmac Approved in USAAlimentary tract & metabolism
Pfizer Zeldox Approved in USA and EUNervous system
Valeant Zelapar Approved in USANervous system
Actelion Zavesca Approved in USA and EUAlimentary tract & metabolism
UCB Pharma Zavesca Approved in USAAlimentary tract & metabolism
Actelion Zavesca in Phase IIIAlimentary tract & metabolism
Actelion Zavesca in Phase IIIAlimentary tract & metabolism
Johnson & Johnson Zarnestra discontinuedAntineoplastic & immunomodulating agents
12345678910...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.